BRPI9909018B8 - processo para a síntese de um peptídeo - Google Patents

processo para a síntese de um peptídeo

Info

Publication number
BRPI9909018B8
BRPI9909018B8 BRPI9909018A BRPI9909018A BRPI9909018B8 BR PI9909018 B8 BRPI9909018 B8 BR PI9909018B8 BR PI9909018 A BRPI9909018 A BR PI9909018A BR PI9909018 A BRPI9909018 A BR PI9909018A BR PI9909018 B8 BRPI9909018 B8 BR PI9909018B8
Authority
BR
Brazil
Prior art keywords
peptide
peptides
synthesis
present
fragments
Prior art date
Application number
BRPI9909018A
Other languages
English (en)
Inventor
Bray Brian
Mader Catherine
Merutka Gene
Lichty Maynard
Kang Myung-Chol
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trimeris Inc filed Critical Trimeris Inc
Priority claimed from PCT/US1999/006230 external-priority patent/WO1999048513A1/en
Publication of BRPI9909018B1 publication Critical patent/BRPI9909018B1/pt
Publication of BRPI9909018B8 publication Critical patent/BRPI9909018B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"processo para a síntese de um peptídeo, conjunto de fragmentos de peptídeo,e,peptídeo". a presente invenção refere-se, primeiro, aos processos de síntese de peptídeos, em particular de t-20 (também referido como "dp178"; seq id no: 1) e de peptídeos semelhantes a t-20. tais processos utilizam procedimentos de síntese em fases liquida e sólida e combinam grupos de fragmentos de peptídeo específicos para dar o peptídeo de interesse. a presente invenção refere-se em adição aos fragmentos de peptídeo individuais que atuam como intermediários na síntese de peptídeos de interesse (por exemplo, t-20). a presente invenção ainda refere-se adicionalmente aos grupos de tais fragmentos de intermediário de peptídeo que podem ser empregados juntos para produzir t-20 de comprimento total e peptídeos semelhantes a t-20.
BRPI9909018A 1998-03-23 1999-03-22 processo para a síntese de um peptídeo BRPI9909018B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/045,920 US6281331B1 (en) 1998-03-23 1998-03-23 Methods and compositions for peptide synthesis
US09/045920 1998-03-23
US09/071,877 US6015881A (en) 1998-03-23 1998-05-01 Methods and compositions for peptide synthesis
US09/071877 1998-05-01
PCT/US1999/006230 WO1999048513A1 (en) 1998-03-23 1999-03-22 Methods and compositions for peptide synthesis

Publications (2)

Publication Number Publication Date
BRPI9909018B1 BRPI9909018B1 (pt) 2019-04-09
BRPI9909018B8 true BRPI9909018B8 (pt) 2021-05-25

Family

ID=21940553

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9909018A BRPI9909018B8 (pt) 1998-03-23 1999-03-22 processo para a síntese de um peptídeo

Country Status (4)

Country Link
US (2) US6281331B1 (pt)
JP (1) JP4755713B2 (pt)
KR (1) KR100633214B1 (pt)
BR (1) BRPI9909018B8 (pt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK782002A3 (en) * 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
US6605427B2 (en) 2000-02-10 2003-08-12 Panacos Pharmaceuticals, Inc. Assay for detection of viral fusion inhibitors
US20050065319A1 (en) * 2000-12-19 2005-03-24 Baroudy Bahige M. Combination method for treating viral infections
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
EP1443963B1 (en) 2001-10-22 2014-05-21 The Scripps Research Institute Antibody targeting compounds
KR100451432B1 (ko) * 2002-07-12 2004-10-06 강충경 Ｔ-20 펩타이드의 생물학적 제조방법
WO2004013165A1 (en) * 2002-07-24 2004-02-12 F. Hoffmann-La Roche Ag Pegylated t1249 polypeptide
HRP20050024A2 (en) * 2002-07-24 2006-02-28 F. Hoffmann - La Roche Ag Pegylated t20 polypeptide
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
EP1542718B1 (en) * 2002-09-24 2015-11-11 Dong Xie Peptide derivative fusion inhibitors of hiv infection
US7556813B2 (en) * 2002-09-27 2009-07-07 Trimeris, Inc. Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides
US20040076637A1 (en) * 2002-09-27 2004-04-22 Delmedico Mary Kay HIV-derived HR1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus
US20040063856A1 (en) * 2002-09-30 2004-04-01 Bohling James Charles Resin for solid phase synthesis
AU2003277378A1 (en) * 2002-10-16 2004-05-04 Panacos Pharmaceuticals, Inc. Method for detecting viral inactivating agents
US20040158037A1 (en) * 2003-02-12 2004-08-12 Bohling James Charles Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
WO2004108885A2 (en) * 2003-05-06 2004-12-16 Syntonix Pharmaceuticals, Inc. Fc chimeric proteins with anti-hiv drugs
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
AU2004238263A1 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
PL2298347T3 (pl) * 2003-05-06 2016-03-31 Bioverativ Therapeutics Inc Białka chimeryczne czynnika krzepnięcia do leczenia zaburzenia hemostazy
KR20050024730A (ko) * 2003-09-01 2005-03-11 코바이오텍 (주) Ｔ―２０ 펩타이드 코딩 유전자를 포함하는 재조합대장균의 고농도 세포 배양 방법 및 이로부터 생산된ｔ―２０ 펩타이드의 분리 및 정제 방법
ATE410437T1 (de) * 2003-12-31 2008-10-15 Hoffmann La Roche Verfahren und systeme zur rückgewinnung von peptiden
EP1701976A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
WO2005063792A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support
WO2005063800A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Peptide synthesis using decanting filter
ATE376556T1 (de) * 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
AU2004313242A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
US20050249667A1 (en) * 2004-03-24 2005-11-10 Tuszynski Jack A Process for treating a biological organism
US20060051396A1 (en) 2004-06-16 2006-03-09 Affinergy, Inc. Biofunctional coatings
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
WO2006069697A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Colorimetrically assessing peptide characteristics
DE602005017206D1 (de) * 2004-12-30 2009-11-26 Hoffmann La Roche Synthese von peptid t-20 mit peptidfragmentzwischenprodukten
WO2006069779A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Preparing of peptides with excellent solubility
JP4886702B2 (ja) * 2004-12-30 2012-02-29 エフ．ホフマン−ラ ロシュ アーゲー ペプチド中間体断片を使用するペプチドｔ−２０の合成
ES2329270T3 (es) * 2004-12-30 2009-11-24 F. Hoffmann-La Roche Ag Sintesis del peptido t-1249 utilizando fragmentos intermediarios del ipeptido.
ES2336245T3 (es) * 2005-04-08 2010-04-09 Lonza Ag Sintesis peptidica de helices alfa sobre resina de peg.
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
WO2007077112A1 (en) * 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Methods for the synthesis of arginine-containing peptides
TWI341844B (en) 2006-02-02 2011-05-11 Trimeris Inc Hiv fusion inhibitor peptides with improved biological properties
TW200745163A (en) 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
CA2651070A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
PT2035451E (pt) * 2006-06-23 2010-06-09 Hoffmann La Roche Síntese de péptidos insulinotrópicos
CA2682848A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics
KR20100036326A (ko) * 2007-06-29 2010-04-07 론자 아게 프람린타이드의 생산 방법
EP2181983A4 (en) * 2007-07-25 2013-01-02 Ajinomoto Kk METHOD FOR THE SELECTIVE REMOVAL OF A DIBENZOFULVENE DERIVATIVE
TW200911289A (en) * 2007-08-09 2009-03-16 Syntonix Pharmaceuticals Inc Immunomodulatory peptides
CN101874038A (zh) * 2007-09-25 2010-10-27 特里梅里斯公司 治疗性抗-hiv肽的合成方法
CN101835794A (zh) * 2007-10-27 2010-09-15 霍夫曼-拉罗奇有限公司 使用固相和溶液相组合技术的促胰岛素肽合成法
US20110014218A1 (en) * 2008-01-25 2011-01-20 University Of North Carolina At Chapel Hill Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway
WO2010014909A1 (en) * 2008-08-01 2010-02-04 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
JP2012517447A (ja) 2009-02-10 2012-08-02 ザ スクリプス リサーチ インスティチュート 化学的にプログラムされたワクチン接種法
US8618049B2 (en) 2009-09-08 2013-12-31 Stephen B. H. Kent Ester insulin
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
TW201217527A (en) 2010-07-09 2012-05-01 Biogen Idec Hemophilia Inc Processable single chain molecules and polypeptides made using same
EP2590997B1 (en) 2010-07-09 2018-04-04 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
WO2014144549A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Factor ix polypeptide formulations
EP3172222A4 (en) 2014-07-24 2018-03-21 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
WO2016187499A1 (en) 2015-05-20 2016-11-24 Syracuse University Improved glycemic control using intrinsic factor bound to a vitamin b12 conjugate of a glucagon-like peptide- 1 receptor agonist
US10716827B2 (en) 2015-05-20 2020-07-21 Syracuse University Compositions and methods for enhancing peptide stability against protease digestion
WO2018181679A1 (ja) * 2017-03-31 2018-10-04 浜理薬品工業株式会社 ペプチドの製造方法
CN115298193B (zh) * 2020-02-05 2026-03-31 伊莱利利公司 串联树脂反应器的肽合成仪

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
US4787222A (en) * 1986-11-24 1988-11-29 Novatek Medical Inc. Combination lock for blood identification system
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
KR100358209B1 (ko) 1992-07-20 2003-01-24 듀크 유니버시티 Hiv복제를저해하는조성물
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
CN1186355C (zh) * 1996-02-09 2005-01-26 霍夫曼-拉罗奇有限公司 血管活性肠肽类似物的合成
WO1999048513A1 (en) * 1998-03-23 1999-09-30 Trimeris, Inc. Methods and compositions for peptide synthesis

Also Published As

Publication number Publication date
KR100633214B1 (ko) 2006-10-11
JP4755713B2 (ja) 2011-08-24
BRPI9909018B1 (pt) 2019-04-09
US6015881A (en) 2000-01-18
KR20010042131A (ko) 2001-05-25
JP2010065044A (ja) 2010-03-25
US6281331B1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
BRPI9909018B8 (pt) processo para a síntese de um peptídeo
BR9909018A (pt) Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
BR0012249A (pt) Método papa sintetizar um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
IL113979A0 (en) Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
BRPI9915679B8 (pt) composições e métodos para aumentar a mineralização óssea
ATE328069T1 (de) Phosphopantethenyltransferasen und deren verwendungen
DK289688A (da) Ekspression af proapolipoprotein a-i.
BR9803807A (pt) Processo para produção de protéina.
BR0206587A (pt) Processo para a produção de uma composição de pantotenato livre de hmbpa, produto, composição de pantotenato livre de hmbpa, composição sintetizada por um microorganismo possuindo uma rota biossintética de pantotenato desregulada, microorganismo recombinante para a produção de composições de pantotenato livres de hmbpa, e, processo para a produção de uma composição de pantotenato: hmbpa seletivamente misturada
BR0115036A (pt) Processo para a preparação de um composto
ATE224443T1 (de) Mch2, eine apoptotische cystein-protease, zusammensetzungen für ihre präparation und methoden für ihre verwendung
AU580350B2 (en) Process for synthesising peptides
IL99079A0 (en) Protein structure of the plant toxin gelonin
MXPA02012378A (es) Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.
EP0770137A4 (en) IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
BR9901089A (pt) Processo para a preparação de ácidos hidroxâmicos.
HUP9903959A2 (hu) Csonkított vérlemezke-aktiváló faktor acetilhidroláz
BR9914775A (pt) Processo quìmico para preparação deintermediários
TW200700555A (en) Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol b
HU9601298D0 (en) Endothelin-converting enzyme
ATE283276T1 (de) Deoxyhypusin reagenz und peptide
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
TW368505B (en) A process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same